<DOC>
	<DOCNO>NCT02790034</DOCNO>
	<brief_summary>This study evaluate safety , tolerability efficacy Sarizotan reduce respiratory abnormality Rett Syndrome .</brief_summary>
	<brief_title>Evaluation Efficacy , Safety , Tolerability Sarizotan Rett Syndrome With Respiratory Symptoms</brief_title>
	<detailed_description>This randomize , double-blind , placebo-controlled study design evaluate safety , tolerability , efficacy multiple dos sarizotan patient Rett syndrome respiratory abnormality . The study participant randomize either sarizotan 2 10 mg bid placebo bid , base age weight criterion .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Rett Syndrome</mesh_term>
	<mesh_term>Signs Symptoms , Respiratory</mesh_term>
	<criteria>Body weight ≥ 10 kg Age ≥ 6 year Diagnosis Rett syndrome base consensus clinical criterion patient MECP2 duplication eligible . Has least 10 episode breathe dysrhythmia , define episode ≥10 second breath hold ( apnea ) , per hour cardiorespiratory monitoring Ability take study medication provide either capsule combine food/drink . Patient cooperative , willing complete aspect study , capable assistance caregiver . Meets diagnostic exclusion criterion Rett syndrome , Typical ( Neul et al , 2010 ) ; Patient participate clinical trial another investigational drug Hypersensitivity sarizotan 5HT1a agonist ; Current clinically significant ( determined Investigator ) cardiovascular , respiratory ( e.g . severe asthma ) , gastrointestinal , renal , hepatic , hematologic medical disorder , addition directly relate patient 's Rett syndrome ; QTcF interval ECG great 450 msec . Surgery plan study ( except insertion gastrostomy tube ) ; Severe diabetes mellitus fatty acid oxidation disorder . Ophthalmologic history include follow condition : albino patient , family history hereditary retinal disease , retinitis pigmentosa , active retinopathy severe diabetic retinopathy . Females pregnant , breastfeeding , childbearing potential use hormonal contraceptive .</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2017</verification_date>
</DOC>